Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies.
Expert Rev Vaccines. 2024 Jan-Dec;23(1):419-431. doi: 10.1080/14760584.2024.2334423. Epub 2024 Apr 2.
Expert Rev Vaccines. 2024.
PMID: 38529685
Free article.
Clinical Trial.
Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study.
Hannawi S, Zhang RR, Abuquta A, Safeldin L, Hassan A, Alamadi A, Hossain T, Mostafa M, Ghoneim Y, Solo J, Zheng HX, Wu DF, Yu DD, Yuan JC, Zhao D, Lin R, Ying B, Qin CF.
Hannawi S, et al. Among authors: safeldin l.
Clin Transl Med. 2023 Aug;13(8):e1387. doi: 10.1002/ctm2.1387.
Clin Transl Med. 2023.
PMID: 37612802
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite